MedPath

Evaluate of Tolterodine for lower urinary tract syndrome after prostate Brachytherapy

Not Applicable
Recruiting
Conditions
Prostate cancer
Registration Number
JPRN-UMIN000004843
Lead Sponsor
Keio University Shool of Medicine Department of Urology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
32
Inclusion Criteria

Not provided

Exclusion Criteria

1. PVR>or=100cc 2. Patient with urinary tract infection 3. Patient of anti-cholinergic medicine administration taboo a. Patient with urinary retention b. Patient whose pylorus or duodenum or ileum are obstructed, or who has paralytic ileus c. Patient whose digestive organ movement or tention are decreased d. Patient with narrow-angle glaucoma e. Patient with myasthenia gravis f. Patient with severe heart disease g. Patient with sevre hepatic dysfunction (Child-Pugh classification C) h. Patient with hypersentivity for anti-cholinergic medicine

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To verify change rate of Overactive Bladder symptom score(OABSS) after 8week
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath